Doctor profile · Federal record
Dr. Alina Voinea, MD
Rheumatology Physician (CMS: Rheumatology) · Little Rock, AR
- NPI 1164482360
- Accepts Medicare
- 33 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
10001 Lile Dr
Little Rock, AR 722056217
(501) 227-8000
fax (501) 221-5886
Credentials & registration
- NPI registered
- March 2006 — 20 yrs on file
- Profile last updated
- March 7, 2023
- Year of graduation
- 1993 — 33 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Arkansas #E-3253
- Medicaid
- AR #146882001
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1164482360. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
75,017
Distinct HCPCS
10
Medicare allowed
$710,323
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 49,700 | 12 | $5 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 14,900 | 16 | $13 | |
J0897 |
Injection, denosumab, 1 mg | 2,040 | 21 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 908 | 388 | $115 | |
36415 |
Insertion of needle into vein for collection of blood sample | 719 | 354 | $8 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 708 | 342 | $8 | |
82565 |
Blood creatinine level | 693 | 336 | $5 | |
84460 |
Liver enzyme (sgpt), level | 682 | 336 | $5 | |
84450 |
Liver enzyme (sgot), level | 680 | 334 | $5 | |
86140 |
Measurement c-reactive protein for detection of infection or inflammation | 598 | 307 | $5 |
In context: peer comparison
Among 9 peers in Little Rock Rheumatology Physician, average services per provider: 2,464. This provider delivers 30× the peer median.Open Payments
Industry payments received
All-time total
$2,249
Transactions
109
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 37 | $708.56 | |
| GlaxoSmithKline, LLC. | 11 | $369.90 | |
| Amgen INC. | 14 | $260.54 | |
| Ucb, INC. | 12 | $231.51 | |
| Pfizer INC. | 17 | $209.57 | |
| Lilly USA, LLC | 7 | $134.47 | |
| AstraZeneca Pharmaceuticals Lp | 1 | $110.58 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $72.75 | |
| Mallinckrodt Hospital Products INC. | 3 | $57.85 | |
| Aurinia Pharma U.S., INC. | 2 | $48.45 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 2 | $44.33 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
4,348
Patients
977
Total drug cost
$1,735,328
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 968 | 187 | $36,641 |
| Hydroxychloroquine Sulfate | Generic | 939 | 209 | $54,495 |
| Prednisone | Generic | 519 | 146 | $5,019 |
| Allopurinol | Generic | 492 | 119 | $7,447 |
| Gabapentin | Generic | 202 | 51 | $3,511 |
| Alendronate Sodium | Generic | 181 | 47 | $1,744 |
| Leflunomide | Generic | 174 | 34 | $8,964 |
| Folic Acid | Generic | 155 | 35 | $682 |
| Duloxetine Hcl | Generic | 137 | 27 | $2,879 |
| Humira(Cf) Pen (Adalimumab) | Brand | 130 | 17 | $1,032,234 |
Frequently asked questions
What is Dr. Alina Voinea's medical specialty?
Dr. Alina Voinea practices Rheumatology Physician in Little Rock, AR.
Where does Dr. Alina Voinea practice?
Dr. Alina Voinea practices at 10001 Lile Dr, Little Rock, AR 722056217. Office phone: 5012278000.
What is Dr. Alina Voinea's NPI?
Dr. Alina Voinea's National Provider Identifier (NPI) is 1164482360, issued by NPPES.
Does Dr. Alina Voinea accept Medicare assignment?
Yes. Dr. Alina Voinea accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Alina Voinea commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.